palladium has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, T; Hester, K; Kirrane, E; Kulikowski, N; Lehmann, DM; Simmons, JE | 1 |
| Bull, JA; Charette, AB; Fortier, A; Ladd, CL; Mousseau, JJ; Sustac Roman, D | 1 |
2 other study(ies) available for palladium and Neurodegenerative Diseases
| Article | Year |
|---|---|
Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: A systematic evidence map protocol.
Topics: Aluminum; Antimony; Antineoplastic Combined Chemotherapy Protocols; Arsenic; Barium; Beryllium; Cadmium; Chromium; Cisplatin; Classification; Cobalt; Copper; Doxorubicin; Environmental Exposure; Humans; Manganese; Mercury; Mitomycin; Neurodegenerative Diseases; Nickel; Palladium; Radium; Review Literature as Topic; Silver; Synucleinopathies; Tauopathies; TDP-43 Proteinopathies; Vanadium; Zinc | 2022 |
Synthesis of 2- and 2,3-substituted pyrazolo[1,5-a]pyridines: scope and mechanistic considerations of a domino direct alkynylation and cyclization of N-iminopyridinium ylides using alkenyl bromides, alkenyl iodides, and alkynes.
Topics: Alkenes; Alkynes; Bromides; Catalysis; Chemistry, Pharmaceutical; Cyclization; Dopamine Agonists; Dopamine Antagonists; Humans; Iodides; Magnetic Resonance Spectroscopy; Neurodegenerative Diseases; Palladium; Pyrazoles; Pyridines; Receptors, Dopamine; Silver | 2011 |